| Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
| Daytime sleepiness | |||||
|
RCT Crossover design |
20 people (AHI 12–93; see table 2 ) |
Subjective measures of daytime sleepiness (ESS score; see table 3
)
2–3 months
6.7 with oral appliance 6.0 with CPAP |
Reported as not significant P value not reported |
Not significant | |
| Intermediate outcomes | |||||
|
Systematic review |
232 people 7 RCTs in this analysis |
Change in AHI (see table 2
)
with oral appliance with nasal CPAP Absolute results not reported |
change in AHI –7.97 episodes/hour 95% CI –9.56 episodes/hour to –6.38 episodes/hour |
Effect size not calculated | nasal CPAP |
|
RCT Crossover design |
20 people (AHI 12–93) |
Sleep-disordered breathing (AHI)
2–3 months
5.3 with oral appliance 0 with CPAP |
Reported as not significant P value not reported |
Not significant | |
| Quality of life | |||||
|
Systematic review |
128 people 2 RCTs in this analysis |
Quality of life (assessed using the Functional Outcomes Sleep Questionnaire; see table 3
)
with oral appliance with nasal CPAP Absolute results not reported |
Difference in score –0.18 95% CI –0.42 to +0.07 |
Not significant |